• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCR3 异构体表达的改变调节前列腺癌细胞的迁移和侵袭。

Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.

机构信息

Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15261, USA.

出版信息

Mol Cancer. 2012 Jan 11;11:3. doi: 10.1186/1476-4598-11-3.

DOI:10.1186/1476-4598-11-3
PMID:22236567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3320557/
Abstract

BACKGROUND

Carcinoma cells must circumvent the normally suppressive signals to disseminate. While often considered 'stop' signals for adherent cells, CXCR3-binding chemokines have recently been correlated positively with cancer progression though the molecular basis remains unclear.

RESULTS

Here, we examined the expression and function of two CXCR3 variants in human prostate cancer biopsies and cell lines. Globally, both CXCR3 mRNA and protein were elevated in localized and metastatic human cancer biopsies compared to normal. Additionally, CXCR3A mRNA level was upregulated while CXCR3B mRNA was downregulated in these prostate cancer specimens. In contrast to normal prostate epithelial cells (RWPE-1), CXCR3A was up to half the receptor in the invasive and metastatic DU-145 and PC-3 prostate cancer cells, but not in the localized LNCaP cells. Instead of inhibiting cell migration as in RWPE-1 cells, the CXCR3 ligands CXCL4/PF4 and CXCL10/IP10 promoted cell motility and invasiveness in both DU-145 and PC-3 cells via PLCβ3 and μ-calpain activation. CXCR3-mediated diminution of cell motility in RWPE-1 cells is likely a result of cAMP upregulation and m-calpain inhibition via CXCR3B signal transduction. Interestingly, overexpression of CXCR3B in DU-145 cells decreased cell movement and invasion.

CONCLUSION

These data suggest that the aberrant expression of CXCR3A and down-regulation of CXCR3B may switch a progression "stop" to a "go" signal to promote prostate tumor metastasis via stimulating cell migration and invasion.

摘要

背景

癌细胞必须规避通常的抑制信号才能扩散。虽然趋化因子受体 3(CXCR3)结合的趋化因子通常被认为是黏附细胞的“停止”信号,但最近它们与癌症进展呈正相关,尽管其分子基础仍不清楚。

结果

在这里,我们检测了两种人前列腺癌活检和细胞系中 CXCR3 变体的表达和功能。与正常组织相比,局部和转移性人癌活检中 CXCR3 mRNA 和蛋白均升高。此外,这些前列腺癌标本中 CXCR3A mRNA 水平上调,而 CXCR3B mRNA 水平下调。与正常前列腺上皮细胞(RWPE-1)相比,侵袭性和转移性 DU-145 和 PC-3 前列腺癌细胞中 CXCR3A 受体约为一半,但在局部 LNCaP 细胞中则不然。与 RWPE-1 细胞中的抑制细胞迁移相反,CXCR3 配体 CXCL4/PF4 和 CXCL10/IP10 通过 PLCβ3 和 μ-钙蛋白酶激活促进 DU-145 和 PC-3 细胞的运动性和侵袭性。CXCR3 介导的 RWPE-1 细胞中细胞迁移减少可能是由于 cAMP 上调和 m-钙蛋白酶通过 CXCR3B 信号转导抑制所致。有趣的是,DU-145 细胞中 CXCR3B 的过表达可降低细胞运动和侵袭。

结论

这些数据表明,CXCR3A 的异常表达和 CXCR3B 的下调可能会通过刺激细胞迁移和侵袭,将进展的“停止”信号转变为“前进”信号,从而促进前列腺肿瘤转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/2ff8cf931aa3/1476-4598-11-3-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/5a2b3c707de1/1476-4598-11-3-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/eaf03cd67ecb/1476-4598-11-3-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/a27dea3a0c0b/1476-4598-11-3-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/b22403fa9286/1476-4598-11-3-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/d4dd28e11c75/1476-4598-11-3-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/7e15e235aa63/1476-4598-11-3-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/2ff8cf931aa3/1476-4598-11-3-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/5a2b3c707de1/1476-4598-11-3-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/eaf03cd67ecb/1476-4598-11-3-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/a27dea3a0c0b/1476-4598-11-3-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/b22403fa9286/1476-4598-11-3-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/d4dd28e11c75/1476-4598-11-3-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/7e15e235aa63/1476-4598-11-3-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6758/3320557/2ff8cf931aa3/1476-4598-11-3-7.jpg

相似文献

1
Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.CXCR3 异构体表达的改变调节前列腺癌细胞的迁移和侵袭。
Mol Cancer. 2012 Jan 11;11:3. doi: 10.1186/1476-4598-11-3.
2
Potential role of CXCR3 in proliferation and invasion of prostate cancer cells.CXCR3在前列腺癌细胞增殖和侵袭中的潜在作用。
Int J Clin Exp Pathol. 2015 Jul 1;8(7):8091-8. eCollection 2015.
3
Disparate roles of CXCR3A and CXCR3B in regulating progressive properties of colorectal cancer cells.CXCR3A 和 CXCR3B 在调节结直肠癌细胞渐进性特征中的不同作用。
Mol Carcinog. 2019 Feb;58(2):171-184. doi: 10.1002/mc.22917. Epub 2018 Oct 9.
4
CXCR3A contributes to the invasion and metastasis of gastric cancer cells.CXCR3A促进胃癌细胞的侵袭和转移。
Oncol Rep. 2016 Sep;36(3):1686-92. doi: 10.3892/or.2016.4953. Epub 2016 Jul 19.
5
Functional Analysis of CXCR3 Splicing Variants and Their Ligands Using NanoBiT-Based Molecular Interaction Assays.使用基于 NanoBiT 的分子相互作用分析方法对 CXCR3 剪接变体及其配体进行功能分析。
Mol Cells. 2023 May 31;46(5):281-297. doi: 10.14348/molcells.2023.2096. Epub 2023 Feb 17.
6
CXCR3 isoform A promotes head and neck cancer progression by enhancing stem-like property and chemoresistance.CXCR3 同工型 A 通过增强干细胞样特性和化疗耐药性促进头颈部癌症的进展。
J Oral Pathol Med. 2022 Oct;51(9):791-800. doi: 10.1111/jop.13346. Epub 2022 Sep 5.
7
Expression of E-cadherin and specific CXCR3 isoforms impact each other in prostate cancer.E-钙黏蛋白和特异性 CXCR3 异构体的表达在前列腺癌中相互影响。
Cell Commun Signal. 2019 Dec 12;17(1):164. doi: 10.1186/s12964-019-0489-1.
8
Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis.CXCR3 变体及其相应 CXC 趋化因子在透明细胞卵巢癌和子宫内膜异位症中的差异表达模式。
Gynecol Oncol. 2011 Sep;122(3):648-55. doi: 10.1016/j.ygyno.2011.05.034.
9
C-X-C motif receptor 3A enhances proliferation and invasiveness of colorectal cancer cells, and is mediated by C-X-C motif ligand 10.C-X-C基序受体3A增强结肠癌细胞的增殖和侵袭能力,并由C-X-C基序配体10介导。
Oncol Lett. 2020 Mar;19(3):2495-2501. doi: 10.3892/ol.2020.11326. Epub 2020 Jan 21.
10
CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production.CXCL10/CXCR3 轴通过 PI3K/AKT 通路依赖性 MMPs 产生促进胃癌的侵袭。
Biomed Pharmacother. 2016 Aug;82:479-88. doi: 10.1016/j.biopha.2016.04.069. Epub 2016 Jun 1.

引用本文的文献

1
CXCR3 inhibitors for therapeutic interventions: current status and perspectives.用于治疗干预的CXCR3抑制剂:现状与展望
Front Pharmacol. 2025 Jul 25;16:1556196. doi: 10.3389/fphar.2025.1556196. eCollection 2025.
2
The metastatic role of the CXCL10-CXCR3 axis and its therapeutic potential in osteosarcoma.CXCL10-CXCR3轴在骨肉瘤中的转移作用及其治疗潜力。
J Bone Oncol. 2025 May 23;52:100690. doi: 10.1016/j.jbo.2025.100690. eCollection 2025 Jun.
3
Mechanisms underlying the promotion of papillary thyroid carcinoma occurrence and progression by Hashimoto's thyroiditis.

本文引用的文献

1
Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis.上皮和间充质表型转换调节转移中的细胞迁移。
Front Biosci (Landmark Ed). 2011 Jan 1;16(3):815-37. doi: 10.2741/3722.
2
TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines.TNFα 暴露的骨髓间充质干细胞通过转录激活 CXCR3 配体趋化因子促进 MDA-MB-231 乳腺癌细胞的迁移。
J Biol Chem. 2010 Oct 1;285(40):30731-40. doi: 10.1074/jbc.M110.128124. Epub 2010 Jul 22.
3
Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.
桥本甲状腺炎促进甲状腺乳头状癌发生和进展的潜在机制。
Front Endocrinol (Lausanne). 2025 Mar 31;16:1551271. doi: 10.3389/fendo.2025.1551271. eCollection 2025.
4
Non-immune targeting of CXCR3 compromises mitochondrial function and suppresses tumor growth in glioblastoma.对CXCR3进行非免疫靶向会损害线粒体功能并抑制胶质母细胞瘤的肿瘤生长。
Cell Death Discov. 2025 Apr 4;11(1):143. doi: 10.1038/s41420-025-02449-1.
5
CXCL10 promotes melanoma angiogenesis and tumor growth.趋化因子CXCL10促进黑色素瘤血管生成和肿瘤生长。
Anim Cells Syst (Seoul). 2024 Sep 11;28(1):453-465. doi: 10.1080/19768354.2024.2402024. eCollection 2024.
6
The roles of tertiary lymphoid structures in genitourinary cancers: molecular mechanisms, therapeutic strategies, and clinical applications.三阴性淋巴结构在泌尿生殖系统癌症中的作用:分子机制、治疗策略和临床应用。
Int J Surg. 2024 Aug 1;110(8):5007-5021. doi: 10.1097/JS9.0000000000001939.
7
The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.促炎细胞因子和 CXC 趋化因子(CXCL1-CXCL16)在前列腺癌进展中的作用:对其治疗管理的深入了解。
Cell Mol Biol Lett. 2024 May 14;29(1):73. doi: 10.1186/s11658-024-00591-9.
8
From biology to the clinic - exploring liver metastasis in prostate cancer.从生物学到临床 - 探索前列腺癌中的肝转移。
Nat Rev Urol. 2024 Oct;21(10):593-614. doi: 10.1038/s41585-024-00875-x. Epub 2024 Apr 26.
9
Pleiotropic Role of Rainbow Trout CXCRs in Response to Disease and Environment: Insights from Transcriptional Signatures and Structure Analysis.虹鳟鱼 CXCR 对疾病和环境的多效性作用:转录特征和结构分析的见解。
Biomolecules. 2024 Mar 12;14(3):337. doi: 10.3390/biom14030337.
10
The duality of CXCR3 in glioblastoma: unveiling autocrine and paracrine mechanisms for novel therapeutic approaches.CXCR3 在胶质母细胞瘤中的双重性:揭示新型治疗方法的自分泌和旁分泌机制。
Cell Death Dis. 2023 Dec 16;14(12):835. doi: 10.1038/s41419-023-06354-2.
乳腺癌细胞在间质到上皮逆转转化过程中重新表达 E-钙黏蛋白。
Mol Cancer. 2010 Jul 7;9:179. doi: 10.1186/1476-4598-9-179.
4
Matrix metalloproteinases: regulators of the tumor microenvironment.基质金属蛋白酶:肿瘤微环境的调节剂。
Cell. 2010 Apr 2;141(1):52-67. doi: 10.1016/j.cell.2010.03.015.
5
CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas.CXCR3/配体在基底细胞癌的肿瘤发生中具有显著作用。
Am J Pathol. 2010 May;176(5):2435-46. doi: 10.2353/ajpath.2010.081059. Epub 2010 Mar 12.
6
Targeted therapy for advanced prostate cancer: Looking through new lenses.晚期前列腺癌的靶向治疗:透过新视角审视
Drug News Perspect. 2009 Dec;22(10):593-601. doi: 10.1358/dnp.2009.10.1428872.
7
Targeted therapeutic approaches for hormone-refractory prostate cancer.针对激素难治性前列腺癌的靶向治疗方法。
Cancer Treat Rev. 2010 Apr;36(2):122-30. doi: 10.1016/j.ctrv.2009.06.001. Epub 2010 Jan 27.
8
Src signaling in cancer invasion.Src 信号在癌症侵袭中的作用。
J Cell Physiol. 2010 Apr;223(1):14-26. doi: 10.1002/jcp.22011.
9
Innovations in the systemic therapy of prostate cancer.前列腺癌系统治疗的创新。
Nat Rev Clin Oncol. 2010 Jan;7(1):13-21. doi: 10.1038/nrclinonc.2009.187. Epub 2009 Dec 8.
10
The roles of cell adhesion molecules in tumor suppression and cell migration: a new paradox.细胞黏附分子在肿瘤抑制和细胞迁移中的作用:一个新的悖论。
Cell Adh Migr. 2009 Oct-Dec;3(4):334-6. doi: 10.4161/cam.3.4.9246. Epub 2009 Oct 12.